Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
Healthcare Quarterly (Toronto, Ont.)
|
August 16, 2011
Improving the patient experience through design
Brian R Golden, Rosemary Hannam, Heather Fraser, et al.
International Journal of Transgender Health
|
October 28, 2024
The 'pet effect' and trans people: Associations between living with animal companions and wellbeing, social support, and trans-related marginalization in three international studies
Georgia E Grey, Gareth J Treharne, Damien W Riggs, et al.
Applied Health Economics and Health Policy
|
November 28, 2023
Adding a Gene Expression Profile Test to Aid Differential Diagnosis and Treatment in Aggressive Large B-Cell Lymphoma: An Early Exploratory Economic Evaluation
Janet Bouttell, Heather Fraser, John R Goodlad, et al.
Vaccine
|
December 4, 2020
A cost-effectiveness analysis of South Africa's seasonal influenza vaccination programme
Ijeoma Edoka, Ciaran Kohli-Lynch, Heather Fraser, et al.
Current Pharmaceutical Biotechnology
|
April 18, 2013
Surfactant and varespladib co-administration in stimulated rat alveolar macrophages culture
Daniele De Luca, Francesca Vendittelli, Joaquim Trias, et al.
Journal of Cardiovascular Pharmacology
|
January 9, 2009
Varespladib (A-002), a secretory phospholipase A2 inhibitor, reduces atherosclerosis and aneurysm formation in ApoE-/- mice
Heather Fraser, Colin Hislop, Robert M Christie, et al.
Influenza and Other Respiratory Viruses
|
March 31, 2022
Costs of seasonal influenza vaccination in South Africa
Heather Fraser, Winfrida Tombe-Mdewa, Ciaran Kohli-Lynch, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
September 21, 2004
Electrophysiologic properties and antiarrhythmic actions of a novel antianginal agent
Charles Antzelevitch, Luiz Belardinelli, Lin Wu, et al.
Addiction Biology
|
June 27, 2019
A randomized, double-blind, placebo-controlled study of the kappa opioid receptor antagonist, CERC-501, in a human laboratory model of smoking behavior
Jermaine D Jones, Shanna Babalonis, Ronald Marcus, et al.
NIHR Open Research
|
August 15, 2024
Baseline Characteristics in the Remote Diet Intervention to REduce long-COVID Symptoms Trial (ReDIRECT)
Laura Haag, Janice Richardson, Caroline Haig, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
Healthcare Quarterly (Toronto, Ont.)
|
August 16, 2011
Improving the patient experience through design
Brian R Golden, Rosemary Hannam, Heather Fraser, et al.
International Journal of Transgender Health
|
October 28, 2024
The 'pet effect' and trans people: Associations between living with animal companions and wellbeing, social support, and trans-related marginalization in three international studies
Georgia E Grey, Gareth J Treharne, Damien W Riggs, et al.
Applied Health Economics and Health Policy
|
November 28, 2023
Adding a Gene Expression Profile Test to Aid Differential Diagnosis and Treatment in Aggressive Large B-Cell Lymphoma: An Early Exploratory Economic Evaluation
Janet Bouttell, Heather Fraser, John R Goodlad, et al.
Vaccine
|
December 4, 2020
A cost-effectiveness analysis of South Africa's seasonal influenza vaccination programme
Ijeoma Edoka, Ciaran Kohli-Lynch, Heather Fraser, et al.
Current Pharmaceutical Biotechnology
|
April 18, 2013
Surfactant and varespladib co-administration in stimulated rat alveolar macrophages culture
Daniele De Luca, Francesca Vendittelli, Joaquim Trias, et al.
Journal of Cardiovascular Pharmacology
|
January 9, 2009
Varespladib (A-002), a secretory phospholipase A2 inhibitor, reduces atherosclerosis and aneurysm formation in ApoE-/- mice
Heather Fraser, Colin Hislop, Robert M Christie, et al.
Influenza and Other Respiratory Viruses
|
March 31, 2022
Costs of seasonal influenza vaccination in South Africa
Heather Fraser, Winfrida Tombe-Mdewa, Ciaran Kohli-Lynch, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
September 21, 2004
Electrophysiologic properties and antiarrhythmic actions of a novel antianginal agent
Charles Antzelevitch, Luiz Belardinelli, Lin Wu, et al.
Addiction Biology
|
June 27, 2019
A randomized, double-blind, placebo-controlled study of the kappa opioid receptor antagonist, CERC-501, in a human laboratory model of smoking behavior
Jermaine D Jones, Shanna Babalonis, Ronald Marcus, et al.
NIHR Open Research
|
August 15, 2024
Baseline Characteristics in the Remote Diet Intervention to REduce long-COVID Symptoms Trial (ReDIRECT)
Laura Haag, Janice Richardson, Caroline Haig, et al.
Page
of 4